Taysha Gene Therapies Stock Analysis

Taysha Stock Analysis Notes

About 18.0% of the company outstanding shares are owned by corporate insiders. The book value of Taysha Gene was at this time reported as 0.33. The company had not issued any dividends in recent years. Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. The company was incorporated in 2019 and is based in Dallas, Texas. Taysha Gene operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 178 people. To find out more about Taysha Gene Therapies contact Sean Nolan at 214 612 0000 or learn more at https://www.tayshagtx.com.

Taysha Gene Therapies Investment Alerts

Taysha Gene Therapies Upcoming and Recent Events

Taysha Largest EPS Surprises

View All Earnings Estimates

Taysha Stock Institutional Investors

Note, although Taysha Gene's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Taysha Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 395.54 M.

Taysha Profitablity

The company has Profit Margin (PM) of (2.3) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (11.78) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $11.78.

Management Efficiency

Taysha Gene Therapies has return on total asset (ROA) of (0.2742) % which means that it has lost $0.2742 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.1477) %, meaning that it created substantial loss on money invested by shareholders. Taysha Gene's management efficiency ratios could be used to measure how well Taysha Gene manages its routine affairs as well as how well it operates its assets and liabilities. As of January 10, 2025, Return On Tangible Assets is expected to decline to -0.61. The current year's Return On Capital Employed is expected to grow to -0.58. At present, Taysha Gene's Net Tangible Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 3.3 M, whereas Total Assets are forecasted to decline to about 169.8 M.

Technical Drivers

As of the 10th of January, Taysha Gene has the Semi Deviation of 5.83, coefficient of variation of 3412.29, and Risk Adjusted Performance of 0.0324. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Taysha Gene Therapies, as well as the relationship between them.

Taysha Gene Therapies Price Movement Analysis

Taysha Gene Therapies Insider Trading Activities

Taysha Gene Outstanding Bonds

Taysha Gene Predictive Daily Indicators

Taysha Gene Forecast Models

Taysha Gene's time-series forecasting models are one of many Taysha Gene's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Taysha Gene's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Taysha Gene prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Taysha shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Taysha Gene. By using and applying Taysha Stock analysis, traders can create a robust methodology for identifying Taysha entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Taysha analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Taysha analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Taysha Gene Therapies stock analysis indicators help investors evaluate how Taysha Gene stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Taysha Gene shares will generate the highest return on investment. By understating and applying Taysha Gene stock analysis, traders can identify Taysha Gene position entry and exit signals to maximize returns.

When running Taysha Gene's price analysis, check to measure Taysha Gene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Taysha Gene is operating at the current time. Most of Taysha Gene's value examination focuses on studying past and present price action to predict the probability of Taysha Gene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Taysha Gene's price. Additionally, you may evaluate how the addition of Taysha Gene to your portfolios can decrease your overall portfolio volatility.